Inhibition of infectious agents by exogenous oligonucleotides
AssigneeHybridon, Inc.
InventorsJohn Goodchild, Paul C. Zamecnik, Sudhir Agrawal
Life of this patent
Estimating the term…
Abstract
Inhibition of replication of an infectious agent, gene expression of an infectious agent, or both, by administration of an oligonucleotide complementary to highly conserved regions of the infectious agent is described.
Drawings
Claims24
An oligonucleotide consisting essentially of a nucleotide sequence complementary to a region of RNA or DNA of an infectious agent, wherein the region of RNA or DNA is selected from the group consisting of regions necessary for replication of the infectious agent, regions necessary for gene expression of the infectious agent, and regions necessary for both replication of the infectious agent and gene expression of the infectious agent, wherein anywhere from one to all internal phosphate groups of said oligonucleotide are modified.
An oligonucleotide consisting essentially of a nucleotide sequence complementary to a region of RNA or DNA of a virus, wherein the region of RNA or DNA is selected from the group consisting of regions necessary for replication of the virus, regions necessary for gene expression of the virus, and regions necessary for both replication of the virus and gene expression of the virus, wherein anywhere from one to all internal phosphate groups of said oligonucleotide are modified.
Dependencies are inferred from the claim text.